baicalin has been researched along with masoprocol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawahito, Y; Matsuyama, M; Mitsuhashi, M; Nakatani, T; Sano, H; Takemoto, Y; Tsuchida, K; Yoshimura, R | 1 |
1 other study(ies) available for baicalin and masoprocol
Article | Year |
---|---|
5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Topics: Aged; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flavonoids; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Lipoxygenase Inhibitors; Male; Masoprocol; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors | 2005 |